INDIAN FACE
INDIAN EQUITY BENCHMARK
Benchmark indices snapped three days winning streak on December 16 after weak WPI inflation for the month of November pulled the Sensex and Nifty Bank from their record highs registered in the early morning trade. At close, the Sensex was down 70.99 points at 40,938.72, while Nifty was down 26 points at 12,060.70. About 1122 shares have advanced, 1342 shares declined, and 207 shares are unchanged. Grasim Industries, Adani Ports, JSW Steel, ITC and Eicher Motors were among major losers on the Nifty, while gainers were TCS, HCL Technologies, Tech Mahindra, Kotak Mahindra Bank and HDFC.
GLOBAL FACE
Asian Market- Asian markets finished mixed as of the most recent closing prices. The Shanghai Composite gained 0.56%, while the Hang Seng led the Nikkei 225 lower. They fell 0.65% and 0.29% respectively
U.S. Market – North and South American markets finished mixed as of their recent closing prices. The IPC gained 2.45% while the Bovespa was higher by 0.33%. The S&P 500 was even.
European markets- European markets are broadly higher
today with shares in London leading the region. The FTSE 100
is up 1.63% while France's CAC 40 is up 0.77% and Germany's
DAX is up 0.53%.
NIFTY SPOT
MARKET TALKS
Ramco Systems surges 3% on signing agreement with China Aircraft Services
Shares of Ramco Systems surged 3% after China Aircraft Services announced that it has signed an agreement with the company to implement its Aviation Suite V5.8 for end-to-end base and line maintenance operations. Through this collaboration, Ramco will provide its integrated Aviation Suite with modules for Maintenance & Engineering, MRO Contracts, Supply Chain, and Finance to help CASL manage their end-to-end line and base maintenance, ground handling and cabin services.
Indoco Remedies jumps ~5% on receiving EU GMP for Goa facility
Indoco Remedies announced that its sterile manufacturing facility (Plant II) at Verna, Goa, has received EU GMP certification from the UK Health Regulator. This is an outcome from the last successful inspection conducted by UK MHRA from 16th to 20th September 2019. Commenting on this positive development, Ms. Aditi Kare Panandikar, Managing Director – Indoco Remedies Ltd. said, “The receipt of EU GMP certification from MHRA for our sterile manufacturing unit is encouraging and reflectsimmense learning and adaptation of a compliant culture by our technical team."
Navin Fluorine extends rally after board approves capex plan
Shares of Navin Fluorine International extended its rally on the BSE. The company is planning a capital expenditure (capex) program at Dahej (Gujarat) through a whollyowned subsidiary with an estimated aggregate capital outlay of over Rs450cr over the next 3-4 years. The board of directors has initially approved the capital expenditure of approximately Rs90cr for site development and related infrastructure on approximately 74 acres of land for greenfield projects at Dahej (Gujarat) through a whollyowned subsidiary, to be incorporated, details of which are annexed, the company said in the press note.
NAME OF THE STOCK : TECHM
DATE : 17/12/2019
SEGMENT : CASH
CHART TYPE : Candlestick
EXCHANGE : NSE
TECHNICAL INDICATORS USED : VOLUME.MACD, RSI.
INVESTMENT ADVICE:
CALL CS CALL: - BUY TECHM CASH NR CMP 773.30 TGT 783 SL 766
RATIONALE FOR ARRIVING INVESTMENT ADVICE :
THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE.
OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL
DISCLAIMER
CAPITALSTARS CALL US : 9977499927
Derivatives Tips , Intraday Stock Tips , FreeTrading Tips, Sebi Registered advisory
INDIAN EQUITY BENCHMARK
Benchmark indices snapped three days winning streak on December 16 after weak WPI inflation for the month of November pulled the Sensex and Nifty Bank from their record highs registered in the early morning trade. At close, the Sensex was down 70.99 points at 40,938.72, while Nifty was down 26 points at 12,060.70. About 1122 shares have advanced, 1342 shares declined, and 207 shares are unchanged. Grasim Industries, Adani Ports, JSW Steel, ITC and Eicher Motors were among major losers on the Nifty, while gainers were TCS, HCL Technologies, Tech Mahindra, Kotak Mahindra Bank and HDFC.
GLOBAL FACE
Asian Market- Asian markets finished mixed as of the most recent closing prices. The Shanghai Composite gained 0.56%, while the Hang Seng led the Nikkei 225 lower. They fell 0.65% and 0.29% respectively
U.S. Market – North and South American markets finished mixed as of their recent closing prices. The IPC gained 2.45% while the Bovespa was higher by 0.33%. The S&P 500 was even.
NIFTY SPOT
JB Chemicals gains on allowance to
raise prices by 50% from the ceiling price
for several formulations
JB Chemicals & Pharmaceuticals notified that the National
Pharmaceuticals Pricing Authority, vide order dated 13th
December 2019, in exercise of its powers under Para 19 of
Drugs (Prices Control) Order, 2013 has, in public interest,
notified one-time price increase of 50% from the present
ceiling price of several formulations including four
formulations of Metronidazole manufactured by the
Company. Ramco Systems surges 3% on signing agreement with China Aircraft Services
Shares of Ramco Systems surged 3% after China Aircraft Services announced that it has signed an agreement with the company to implement its Aviation Suite V5.8 for end-to-end base and line maintenance operations. Through this collaboration, Ramco will provide its integrated Aviation Suite with modules for Maintenance & Engineering, MRO Contracts, Supply Chain, and Finance to help CASL manage their end-to-end line and base maintenance, ground handling and cabin services.
Indoco Remedies jumps ~5% on receiving EU GMP for Goa facility
Indoco Remedies announced that its sterile manufacturing facility (Plant II) at Verna, Goa, has received EU GMP certification from the UK Health Regulator. This is an outcome from the last successful inspection conducted by UK MHRA from 16th to 20th September 2019. Commenting on this positive development, Ms. Aditi Kare Panandikar, Managing Director – Indoco Remedies Ltd. said, “The receipt of EU GMP certification from MHRA for our sterile manufacturing unit is encouraging and reflectsimmense learning and adaptation of a compliant culture by our technical team."
Navin Fluorine extends rally after board approves capex plan
Shares of Navin Fluorine International extended its rally on the BSE. The company is planning a capital expenditure (capex) program at Dahej (Gujarat) through a whollyowned subsidiary with an estimated aggregate capital outlay of over Rs450cr over the next 3-4 years. The board of directors has initially approved the capital expenditure of approximately Rs90cr for site development and related infrastructure on approximately 74 acres of land for greenfield projects at Dahej (Gujarat) through a whollyowned subsidiary, to be incorporated, details of which are annexed, the company said in the press note.
NAME OF THE STOCK : TECHM
DATE : 17/12/2019
SEGMENT : CASH
CHART TYPE : Candlestick
EXCHANGE : NSE
TECHNICAL INDICATORS USED : VOLUME.MACD, RSI.
INVESTMENT ADVICE:
CALL CS CALL: - BUY TECHM CASH NR CMP 773.30 TGT 783 SL 766
RATIONALE FOR ARRIVING INVESTMENT ADVICE :
THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE.
OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL
DISCLAIMER
The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decisions. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. CapitalStars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk.
CLICK HERE FOR GETTING DETAILS & JOIN OUR BEST ADVISORY -
CAPITALSTARS CALL US : 9977499927
Derivatives Tips , Intraday Stock Tips , FreeTrading Tips, Sebi Registered advisory
0 Comments